CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

of hepatitis B and C virus infection in patients attending tertiary care hospital, New Delhi

Author: 
Megha Rastogi, Swati Sharma, Abhijit Das, Madhu Sinha, Man Mohan Mehndiratta
Subject Area: 
Life Sciences
Abstract: 

Background: Hepatitis is a serious public health problem worldwide and major causes of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Chronic hepatitis B virus (HBV) infection accounts for 40-50% of HCC and 20-30% cases of cirrhosis in India. Chronic hepatitis C virus (HCV) infection accounts for 12-32% of hepatocellular carcinoma (HCC) and 12-20% of cirrhosis. Materials and method: It is a prospective study conducted in the department of Microbiology at tertiary care hospital, New Delhi over a period of one year from January 2018 to December 2018.About 5ml of blood was aseptically collected by venepuncture from each subject. All serum samples were tested for HBsAg and IgM anti-HCV by chemiluminescence immunoassay (CLIA).Those samples which were reactive by CLIA were again tested by rapid card test principle of which is immunochromatography. Results: Out of 3566 patients screened for HBsAg,126 patients were reactive to HBsAg, this includes 80 (3.58%) males and 46 (3.46%) females. Out of3524 patients were screened for anti-HCV, 157 patients were reactive to anti-HCV, this includes 96 (4.33%) males and 61 (4.67%) females. The distribution of HBsAg according to age showed that those between 21-30 years had higher prevalence of 7.39% followed by 11-20 years 5.38%, 70-81 years 3.82%, 41-50 years 3.11%, 31-40 years 3.06%, 51-60 years 2.57%, 61-70 years 1.74%, 1-10 years 0%, 81-90 years 0% and 91-100 years 0%.The distribution of anti-HCV according to age showed that those between81-90 years had highest prevalence of 7.41% followed by 31-40 years 4.95%, 51-60 years 5.30%,41-50 years 5.16%, 31-40 years 4.95%, 61-70 years 4.09%,21-30 years 3.75%, 11-20 years 2.16%, 71-80 years 1.57%, 1-10 years 0% and 91-100 years 0%. Conclusion: Keeping in view, the increasing burden of this disease, there is need to increase the public awareness as to how the infection can be prevented by taking simple precautions.

PDF file: 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran